Fatty liver index as a simple predictor of incident diabetes from the KoGES-ARIRANG study

Medicine (United States)

Volumn 95, Issue 31, 2016, Pages

  Yadav, Dhananjay ^a   Choi, Eunhee ^a   Ahn, Song Vogue ^a   Koh, Sang Baek ^a   Sung, Ki Chul ^b   Kim, Jang Young ^a   Huh, Ji Hye ^a  

^a Yonsei University Wonju   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

diabetes mellitus; fatty liver index; integrated discrimination index; net reclassification improvement; prospective study

Indexed keywords

ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; FATTY LIVER INDEX; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NONALCOHOLIC FATTY LIVER; ODDS RATIO; POPULATION BASED CASE CONTROL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; BLOOD; BODY MASS; COMORBIDITY; INCIDENCE; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; SOUTH KOREA; STATISTICAL MODEL; WAIST CIRCUMFERENCE;

ADULT; AGED; BIOMARKERS; BODY MASS INDEX; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; ROC CURVE; WAIST CIRCUMFERENCE;

EID: 84983316622     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000004447     Document Type: Article

References (30)

1. Jeong EH, Jun DW, Cho YK, et al. Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea. Clin Mol Hepatol 2013;19:266-72.
2. Lee JY, Kim KM, Lee SG, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 2007;47:239-44.
3. Yki-Jarvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2014;2:901-10.
4. Souza MR, Diniz Mde F, Medeiros-Filho JE, et al. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease. Arq Gastroenterol 2012;49:89-96.
5. Stefan N, Haring HU. The role of hepatokines in metabolism. Nat Rev Endocrinol 2013;9:144-52.
6. Sung KC, Kim SH. Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes. J Clin Endocrinol Metab 2011;96:1093-7.
7. Kim CH, Park JY, Lee KU, et al. Fatty liver is an independent risk factor for the development of type 2 diabetes in Korean adults. Diabet Med 2008;25:476-81.
8. Cusi K. Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes 2009;16:141-9.
9. Jager S, Jacobs S, Kroger J, et al. Association between the fatty liver index and risk of type 2 diabetes in the EPIC-Potsdam Study. PLoS One 2015;10:e0124749.
10. Jung CH, LeeWJ, Hwang JY, et al. Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population. Diabet Med 2013;30:428-35.
11. Barsic N, Lerotic I, Smircic-Duvnjak L, et al. Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease. World J Gastroenterol 2012;18:3945-54.
12. Sahani DV, Kalva SP. Imaging the liver. Oncologist 2004;9:385-97.
13. Bedogni G, Bellentani S, Miglioli L, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006;6:33.
14. Kim JH, Kwon SY, Lee SW, et al. Validation of fatty liver index and lipid accumulation product for predicting fatty liver in Korean population. Liver Int 2011;31:1600-1.
15. Balkau B, Lange C, Vol S, et al. Nine-year incident diabetes is predicted by fatty liver indices: the French D. E. S. I. R. study. BMC Gastroenterol 2010;10:56.
16. Koh SB, Yoon J, Kim JY, et al. Relationships between serum adiponectin with metabolic syndrome and components of metabolic syndrome in non-diabetic Koreans: ARIRANG study. Yonsei Med J 2011;52: 234-41.
17. Kim JY, Ahn SV, Yoon JH, et al. Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study. Diabetes Care 2013;36:1547-53.
18. Yadav D, Lee ES, Kim HM, et al. Prospective study of serum uric acid levels and incident metabolic syndrome in a Korean rural cohort. Atherosclerosis 2015;241:271-7.
19. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-9.
20. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care 2012;35(suppl 1):S11-63.
21. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-72. discussion 207-212.
22. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116:1793-801.
23. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860-7.
24. Park SK, Seo MH, Shin HC, et al. Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study. Hepatology 2013;57: 1378-83.
25. Sung KC, Wild SH, Byrne CD. Resolution of fatty liver and risk of incident diabetes. J Clin Endocrinol Metab 2013;98:3637-43.
26. OkamotoM, Takeda Y, Yoda Y, et al. The association of fatty liver and diabetes risk. J Epidemiol 2003;13:15-21.
27. Shibata M, Kihara Y, TaguchiM, et al. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 2007;30:2940-4.
28. Kahl S, Strassburger K, Nowotny B, et al. Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance. PLoS One 2014;9:e94059.
29. Chang Y, Jung HS, Yun KE, et al. Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population. Am J Gastroenterol 2013;108:1861-8.
30. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011;30:11-21.